Asia FX rises; US-Japan trade deal boosts yen, won to 2-week highs
Cathie Wood’s ARK ETFs have once again made significant moves in the stock market on Tuesday, 22 July 2025, with the largest transaction being the purchase of shares in Teradyne Inc (NASDAQ:TER). The investment management firm, known for its focus on disruptive innovation, bought 39,792 shares of Teradyne, a provider of automated test equipment, with the total dollar value of the trade amounting to approximately $3.77 million.
This move comes as part of ARK’s strategy to invest in companies they believe are leading the next wave of technological innovation. Teradyne has been a recurring interest for ARK, as seen in previous trades, including a buy of 4,189 shares on Wednesday, 16 July.
On the selling side, ARK reduced its holdings in Meta Platforms Inc (NASDAQ:META), formerly known as Facebook, by offloading 2,106 shares. The sale is valued at around $1.5 million and continues a trend of ARK divesting from the social media giant, which has been a part of their trading activity in recent days.
In the realm of healthcare, ARK’s ARKG ETF has continued its investment in Caris Life Sciences Inc (CAI), adding 13,036 shares to its portfolio. The transaction is valued at approximately $368,788, mirroring an identical purchase made on Friday, 18 July. Meanwhile, ARK has sold 3,013 shares of Guardant Health Inc (NASDAQ:GH), a precision oncology company, for a total of $137,513.
These trades are part of ARK’s daily adjustments to its ETF portfolios, as the firm seeks to capitalize on market dynamics and align with its long-term investment strategy. Investors and market watchers closely follow ARK’s trades, as Cathie Wood’s investment decisions are often seen as indicators of broader market trends in innovation-focused sectors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.